Efficacy of a BCNU-based high dose conditioning regimen (CBV1) followed by autologous hematopoietic stem cell transplantation (HSCT) in relapsed or refractory Hodgkin's disease (HD).

被引：0
|
作者：
Qazilbash, MH [1 ]
Lynch, JP [1 ]
Beall, CL [1 ]
Auber, M [1 ]
Weisenborn, R [1 ]
Bunner, P [1 ]
Hobbs, G [1 ]
Ericson, SG [1 ]
机构：
[1] W Virginia Univ, BMT Sect, Morgantown, WV 26506 USA
来源：
BLOOD | 2000年 / 96卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5369
引用
收藏
页码：374B / 374B
页数：1
相关论文
共 50 条
  • [1] High dose therapy and autologous hematopoietic stem cell transplantation (auto HSCT) with an intensive VCB conditioning regimen for relapsed and refractory Hodgkin's disease (HD).
    Alam, AR
    Younis, T
    Hahn, T
    Bernstein, Z
    Chanan-Khan, AA
    Czuczman, M
    Silva, J
    Becker, J
    McCarthy, P
    BLOOD, 2002, 100 (11) : 863A - 864A
  • [2] Efficacy and toxicity of CCNU-based high dose chemotherapy followed by autologous hematopoietic cell transplantation (HCT) in relapsed or refractory Hodgkin's disease (HD).
    Jain, M
    Chao, NJ
    Horning, SJ
    Negrin, RS
    Hu, WW
    Johnston, LJ
    Shizuru, JA
    Long, GD
    Blume, KG
    Stockerl-Goldstein, KE
    BLOOD, 1999, 94 (10) : 169A - 169A
  • [3] Efficacy and toxicity of a CCNU-containing high-dose chemotherapy regimen followed by autologous hematopoietic cell transplantation in relapsed or refractory Hodgkin's disease
    Stuart, MJ
    Chao, NS
    Horning, SJ
    Wong, RM
    Negrin, RS
    Johnston, LJ
    Shizuru, JA
    Long, GD
    Blume, KG
    Stockerl-Goldstein, KE
    Goldstein, S
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2001, 7 (10) : 552 - 560
  • [4] Effectiveness of hematopoietic stem cell transplantation (HSCT) for relapsed Hodgkin's disease (HD) in children
    Baker, KS
    Gordon, BG
    Gross, TG
    Harper, JL
    Warkentin, PI
    Pennington, M
    Coccia, PF
    Abromowitch, MA
    BLOOD, 1996, 88 (10) : 482 - 482
  • [5] High-dose sequential followed by autologous hematopoietic stem cell transplantation for Hodgkin's disease (hd): a Brazilian experience
    Duarte, B.
    Valente, I.
    Vigorito, A.
    Aranha, F.
    Oliveira, G.
    Miranda, E.
    Lorand-Metze, I.
    Pagnano, K.
    De Souza, C.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S246 - S246
  • [6] High dose chemotherapy followed by autologous stem cell transplantation for relapsed or refractory Hodgkin's lymphoma.
    Holland, D. W.
    Engelhardt, B. G.
    Goodman, S. A.
    Greer, J. P.
    Morgan, D. S.
    Schuening, F. G.
    Wolff, S.
    Bitting, R.
    Sulur, P.
    Stein, R. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 434S - 434S
  • [7] High-dose etoposide, cytarabine and melphalan as conditioning regimen for autologous stem cell transplantation in patients with refractory or relapsed Hodgkin's lymphoma
    Bekadja, M. A.
    Osmani, S.
    Brahimi, M.
    Talhi, S.
    Bekadja, S.
    Belkhodja, S.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S446 - S446
  • [8] Treatment of relapsed or refractory non-Hodgkin's lymphoma (NHL) or Hodgkin's disease (HD) with high-dose chemotherapy and autologous hematopoietic stem cell transplantation (HSCT) using a novel mitoxantrone-containing preparative regimen.
    Andritsos, Leslie
    Suhre, Wendy
    Nahirny, Mark
    Chase, Ellen
    Carroll, Michael
    Christian, Jennifer
    Miller, Thomas P.
    Yeager, Andrew M.
    BLOOD, 2006, 108 (11) : 408B - 408B
  • [9] MCVAC Conditioning Regimen Followed by Autologous Hematopoietic Stem Cell Transplantation in Patients With Relapsed and Refractory Hodgkin Lymphoma: A Single-Institution Retrospective Study
    Naganuma, Ken
    Takahashi, Yasuyuki
    Anan, Tomoe
    Kubota, Yasushi
    Momose, Shuji
    Higashi, Morihiro
    Tamaru, Jun-ichi
    Kizaki, Masahiro
    Tabayashi, Takayuki
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S409 - S409
  • [10] Intensive conditioning regimen of etoposide (VP-16), cyclophosphamide and carmustine (VCB) followed by autologous hematopoietic stem cell transplantation for relapsed and refractory Hodgkin's lymphoma
    Benekli, M.
    Smiley, S. L.
    Younis, T.
    Czuczman, M. S.
    Hernandez-Ilizaliturri, F.
    Bambach, B.
    Battiwalla, M.
    Padmanabhan, S.
    McCarthy, P. L., Jr.
    Hahn, T.
    BONE MARROW TRANSPLANTATION, 2008, 41 (07) : 613 - 619
12345